These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


98 related items for PubMed ID: 7624124

  • 21. Serum starved v-mos-transformed cells are unable to appropriately downregulate cyclins and CDKs.
    Rhodes N, Innes CL, Propst F, Paules RS.
    Oncogene; 1997 Jun 26; 14(25):3017-27. PubMed ID: 9223665
    [Abstract] [Full Text] [Related]

  • 22. Implication of GAP in Ras-dependent transactivation of a polyoma enhancer sequence.
    Schweighoffer F, Barlat I, Chevallier-Multon MC, Tocque B.
    Science; 1992 May 08; 256(5058):825-7. PubMed ID: 1317056
    [Abstract] [Full Text] [Related]

  • 23. Transformation-resistant mos revertant is unable to activate MAP kinase kinase in response to v-mos or v-raf.
    Topol LZ, Marx M, Calothy G, Blair DG.
    Cell Growth Differ; 1995 Jan 08; 6(1):27-38. PubMed ID: 7718484
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Targets of B lymphocyte antigen receptor signal transduction include the p21ras GTPase-activating protein (GAP) and two GAP-associated proteins.
    Gold MR, Crowley MT, Martin GA, McCormick F, DeFranco AL.
    J Immunol; 1993 Jan 15; 150(2):377-86. PubMed ID: 8419471
    [Abstract] [Full Text] [Related]

  • 33. Increased levels of p21ras-GTP and enhanced DNA synthesis accompany elevated tyrosyl phosphorylation of GAP-associated proteins, p190 and p62, in c-src overexpressors.
    Chang JH, Wilson LK, Moyers JS, Zhang K, Parsons SJ.
    Oncogene; 1993 Apr 15; 8(4):959-67. PubMed ID: 7681161
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Repression of mitogen-activated protein kinases ERK1/ERK2 activity by a protein tyrosine phosphatase in rat fibroblasts transformed by upstream oncoproteins.
    Gopalbhai K, Meloche S.
    J Cell Physiol; 1998 Jan 15; 174(1):35-47. PubMed ID: 9397154
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2).
    Koong AC, Chen EY, Mivechi NF, Denko NC, Stambrook P, Giaccia AJ.
    Cancer Res; 1994 Oct 15; 54(20):5273-9. PubMed ID: 7923153
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Suppression of src transformation by overexpression of full-length GTPase-activating protein (GAP) or of the GAP C terminus.
    DeClue JE, Zhang K, Redford P, Vass WC, Lowy DR.
    Mol Cell Biol; 1991 May 15; 11(5):2819-25. PubMed ID: 2017179
    [Abstract] [Full Text] [Related]

  • 40. Radicicol leads to selective depletion of Raf kinase and disrupts K-Ras-activated aberrant signaling pathway.
    Soga S, Kozawa T, Narumi H, Akinaga S, Irie K, Matsumoto K, Sharma SV, Nakano H, Mizukami T, Hara M.
    J Biol Chem; 1998 Jan 09; 273(2):822-8. PubMed ID: 9422737
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.